RIL
Descriptions, notes, and TILs marked with this icon are AI-generated. Pencil icon means my own words.
This is real, ongoing curation — everything here is something I've actually read, listened to, or watched and saved, not sample data. Set up your own instance.

#health-policy

2 items

Links

article pub. Aug 4, 2026

FDA Advisory Committee's Vote May Open A Drug-Compounding Back Door For Unapproved Peptides

https://www.healthaffairs.org/content/forefront/fda-advisory-committee-s-vote-may-open-drug-compounding-back-door-unapproved-peptides

Health Affairs Forefront analysis by Mengyuan Fu, Joseph S. Ross, Ngoc-Trang Adrienne H. Nguyen, and Reshma Ramachandran of the FDA Pharmacy Compounding Advisory Committee's July 2026 vote to add six unapproved peptides (BPC-157, KPV, TB-500, MOTS-c, Epitalon, Semax) to the 503A Bulks List despite FDA scientists finding insufficient evidence of benefit, safety, or manufacturing quality, and documents financial conflicts of interest among the voting committee members.

#fda #peptides #drug-compounding #health-policy #conflicts-of-interest
video pub. Aug 3, 2026

Pressure Points: The Complicated Drivers of Health Costs

https://www.youtube.com/watch?v=kDqSva5489Y

Healthcare Triage (in partnership with AcademyHealth) breaks down why US health care spending, at about 18% of GDP and nearly double many peer countries, keeps rising: not one villain but a stack of higher prices, rising utilization of new treatments added on top of old ones, coverage gaps, administrative overhead, and underfunded chronic-disease prevention.

#health #healthcare-costs #health-policy #economics #public-health